Literature DB >> 12916743

Yusho in Japan.

Takesumi Yoshimura1.   

Abstract

The aim of the present paper is to summarize the history of the Yusho incidence that occurred in the western part of Japan in 1968. A strange disease was reported in October 1968. This strange disease was characterized by acne-like eruptions, pigmentation of the skin, and eye discharge, and it was named Yusho (oil disease). Through systematic epidemiological studies based on observation of initial case series, and extensive efforts to clarify causal agents by the Study Group for Yusho, it was concluded that Yusho was caused by ingestion of rice oil contaminated with PCBs and PCDFs. As of now, more than 1,800 patients, have been registered as having Yusho and around 300 are deceased. Clinical observation showed that typical symptoms of Yusho have decreased, even general fatigue, headache and numbness of extremities have still been complained by patients. No effective treatment has been found so far. Careful and systematic observation for Yusho patients and medical care services should be continued for a further understanding of Yusho.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916743     DOI: 10.2486/indhealth.41.139

Source DB:  PubMed          Journal:  Ind Health        ISSN: 0019-8366            Impact factor:   2.179


  14 in total

Review 1.  Dioxin risk assessment: mechanisms of action and possible toxicity in human health.

Authors:  Seyedeh Belin Tavakoly Sany; Rosli Hashim; Aishah Salleh; Majid Rezayi; David J Karlen; Bi Bi Marzieh Razavizadeh; Ebrahim Abouzari-Lotf
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-29       Impact factor: 4.223

Review 2.  Biomarkers of metabolic disorders and neurobehavioral diseases in a PCB- exposed population: What we learned and the implications for future research.

Authors:  Jyothirmai J Simhadri; Christopher A Loffredo; Tomas Trnovec; Lubica Palkovicova Murinova; Gail Nunlee-Bland; Janna G Koppe; Greet Schoeters; Siddhartha Sankar Jana; Somiranjan Ghosh
Journal:  Environ Res       Date:  2020-09-13       Impact factor: 6.498

3.  Twenty-year changes of penta-chlorodibenzofuran (PeCDF) level and symptoms in Yusho patients, using association analysis.

Authors:  Shinya Matsumoto; Yoshiyuki Kanagawa; Soichi Koike; Manabu Akahane; Hiroshi Uchi; Satoko Shibata; Masutaka Furue; Tomoaki Imamura
Journal:  BMC Res Notes       Date:  2010-05-05

4.  In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner.

Authors:  Nicolò Costantino Brembilla; Jean-Marie Ramirez; Rachel Chicheportiche; Olivier Sorg; Jean-Hilaire Saurat; Carlo Chizzolini
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

5.  Prenatal exposure to polychlorinated biphenyls and postnatal growth: a structural analysis.

Authors:  Matthew R Lamb; Sylvia Taylor; Xinhua Liu; Mary S Wolff; Luisa Borrell; Thomas D Matte; Ezra S Susser; Pam Factor-Litvak
Journal:  Environ Health Perspect       Date:  2006-05       Impact factor: 9.031

6.  PCDD and PCDF exposures among fishing community through intake of fish and shellfish from the Straits of Malacca.

Authors:  Azrina Azlan; Nurul Nadiah Mohamad Nasir; Norashikin Shamsudin; Hejar Abdul Rahman; Hock Eng Khoo; Muhammad Rizal Razman
Journal:  BMC Public Health       Date:  2015-07-21       Impact factor: 3.295

7.  Cutaneous symptoms such as acneform eruption and pigmentation are closely associated with blood levels of 2,3,4,7,8-penta-chlorodibenzofurans in Yusho patients, using data mining analysis.

Authors:  Tomoaki Imamura; Shinya Matsumoto; Manabu Akahane; Yoshiyuki Kanagawa; Soichi Koike; Bunichi Tajima; Shiro Matsuya; Hiroshi Uchi; Satoko Shibata; Masutaka Furue
Journal:  BMC Res Notes       Date:  2009-02-25

Review 8.  Facing the challenge of data transfer from animal models to humans: the case of persistent organohalogens.

Authors:  Alexander Suvorov; Larissa Takser
Journal:  Environ Health       Date:  2008-11-13       Impact factor: 5.984

9.  Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients.

Authors:  Shinya Matsumoto; Manabu Akahane; Yoshiyuki Kanagawa; Jumboku Kajiwara; Chikage Mitoma; Hiroshi Uchi; Masutaka Furue; Tomoaki Imamura
Journal:  Environ Health       Date:  2015-09-17       Impact factor: 5.984

10.  Change in decay rates of dioxin-like compounds in Yusho patients.

Authors:  Shinya Matsumoto; Manabu Akahane; Yoshiyuki Kanagawa; Jumboku Kajiwara; Chikage Mitoma; Hiroshi Uchi; Masutaka Furue; Tomoaki Imamura
Journal:  Environ Health       Date:  2016-09-07       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.